Loading...
Home 2018-11-08T20:37:26+00:00

Oncobiologics…

…is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) therapeutics.

BioSymphony Platform Icon

BioSymphony Platform

By leveraging our proprietary BioSymphony™ Platform, Oncobiologics is able to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.

Biosimilars Icon

BIOSIMILARS

We cost-effectively develop biosimilars candidates on an accelerated timeline

Innovative mAb Therapeutics Icon

NOVEL THERAPEUTICS

Our strategy includes developing innovative mAb candidates